B

Beijing Biostar Pharmaceuticals Co Ltd
HKEX:2563

Watchlist Manager
Beijing Biostar Pharmaceuticals Co Ltd
HKEX:2563
Watchlist
Price: 4.4 HKD 0.69% Market Closed
Market Cap: HK$1.6B

P/FCFE

0
Current
No historical data
Comparison unavailable

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
0
=
Market Cap
HK$0
/
Free Cash Flow to Equity
¥0

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
0
=
Market Cap
HK$0
/
Free Cash Flow to Equity
¥0

Valuation Scenarios

Beijing Biostar Pharmaceuticals Co Ltd is trading above its industry average

If P/FCFE returns to its Industry Average (37.1), the stock would be worth HK$0 (100% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
100%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 0 HK$4.4
0%
Industry Average 37.1 HK$0
-100%
Country Average 26.4 HK$0
-100%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
CN
B
Beijing Biostar Pharmaceuticals Co Ltd
HKEX:2563
Average P/E: 8 516.1
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.4
1%
10.4
US
F
Fintech Ecosystem Development Corp
NASDAQ:FEXD
38 368.9
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
47%
N/A
US
Coupang Inc
F:788
173.5
96%
1.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 256.9 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.9
-5%
N/A

Market Distribution

Not Available
No Country distribution data available for this multiple

Beijing Biostar Pharmaceuticals Co Ltd
Glance View

Market Cap
1.6B HKD
Industry
N/A

Nestled amidst the bustling landscape of China's pharmaceutical industry, Beijing Biostar Pharmaceuticals Co Ltd has carved out a niche by merging traditional Chinese medicine with modern biotechnology. Founded with a vision to revolutionize healthcare, Biostar blends age-old herbal practices with cutting-edge research, producing a diverse range of health products. It positions itself uniquely by focusing on high-quality, innovative treatments that cater to an aging population seeking alternative therapies. The company thrives on its state-of-the-art research facilities and a team of dedicated scientists who constantly evolve and refine their product offerings. This strategy not only helps in preserving traditional knowledge but also enhances market appeal among a growing base of health-conscious consumers. Revenue generation at Beijing Biostar Pharmaceuticals follows a multifaceted approach. The company capitalizes on its extensive product line, which includes everything from dietary supplements to therapeutic pharmaceutical products. Robust manufacturing capabilities allow it to control the production process, ensuring quality and efficiency. Furthermore, Biostar leverages an expansive distribution network, both domestically and overseas, to broaden its market reach. Strategic partnerships with hospitals and clinics further bolster its sales channels, providing a steady flow of income. The company's commitment to research and development is mirrored in its collaboration with academic institutions, fostering innovation and securing intellectual property that promises sustainable growth in a competitive market.

Intrinsic Value
Not Available
B
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett